XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.3
EARNINGS PER SHARE
9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
EARNINGS PER SHARE EARNINGS PER SHARE
The Company calculates basic earnings per share by dividing the net income (loss) by the weighted average number of shares of common stock outstanding for the period. The diluted earnings (loss) per share is computed by assuming the exercise, settlement, and vesting of all potential dilutive common stock equivalents outstanding for the period using the treasury stock method.
The following table sets forth a reconciliation of the numerator and denominator used to compute basic earnings and diluted per share of common stock (in thousands, except per share data):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Numerator
Net loss from continuing operations$(6,324)$(13,161)$(15,867)$(31,756)
Loss from discontinued operations, net of tax(43)(1,078)(12)(696)
Net loss$(6,367)$(14,239)$(15,879)$(32,452)
Denominator
Basic weighted average shares outstanding10,652 7,262 10,040 6,341 
Effect of dilutive securities— — — — 
Diluted weighted average shares outstanding10,652 7,262 10,040 6,341 
Net (loss) income per share, basic and diluted:
Net loss per share from continuing operations, basic and diluted$(0.60)$(1.81)$(1.58)$(5.01)
Loss per share from discontinued operations, basic and diluted0.00 (0.15)0.00 (0.11)
Net loss per share, basic and diluted$(0.60)$(1.96)$(1.58)$(5.12)
For the three and nine months ended September 30, 2024 and 2023, because the Company was in a loss position, basic net loss per share is the same as diluted net loss per share, as the inclusion of the potential common shares would have been anti-dilutive.
The following table sets forth potential shares of common stock that are not included in the diluted net loss per share calculation because to do so would be anti-dilutive for the period indicated (in thousands):
Anti-dilutive securitiesSeptember 30, 2024September 30, 2023
Restricted stock units16012
Common shares issuable upon exercise of stock options483360
Common shares issuable upon exercise of warrants1,441
Total2,084372